Suppr超能文献

连续玻璃体内注射对干眼评估指标的影响:系统评价和荟萃分析。

Influence of serial intravitreal injections on measures of dry eye: A systemic review and meta-analysis.

机构信息

Department of Ophthalmology, Affiliated Hospital of Weifang Medical University, Weifang 261042, China; Department of Ophthalmology and Visual Science, University of Massachusetts Chan Medical School, Worcester 01605, MA, USA.

Department of Ophthalmology, Affiliated Hospital of Weifang Medical University, Weifang 261042, China.

出版信息

Cont Lens Anterior Eye. 2024 Apr;47(2):102127. doi: 10.1016/j.clae.2024.102127. Epub 2024 Feb 13.

Abstract

PURPOSE

The aim of this study was to evaluate the long-term effects of serial intravitreal injections (IVI) on measures of dry eye.

METHODS

The PubMed, EMBASE, and Cochrane databases were searched according to the PROSPERO protocol (CRD42023455727). Studies evaluating the influence of serial IVI on the ocular surface compared with untreated fellow eyes were included. The measures of dry eye after IVI were used as outcome variables. The results are presented as mean difference (MD) with a corresponding 95% confidence interval (CI).

RESULTS

A total of 4 studies with 259 participants were included in this meta-analysis. Significant increases in ocular surface disease index (OSDI) scores (MD 10.26, 95 % CI 5.05 to 15.46, p < 0.01) and tear film osmolarity (TOsm; MD 4.40, 95 % CI 0.87 to 7.92, p = 0.01) were observed in the IVI treated eyes compared to the untreated fellow eyes. There was no significant difference between the groups with respect to fluorescein tear film break-up time (TBUT; p = 0.05), average non-invasive tear film break-up time (NITBUT; p = 0.94), first NITBUT (p = 0.78) and Schirmer test (p = 0.94).

CONCLUSION

Repeated IVI of anti-VEGF agents with preoperative povidone-iodine application was associated with increased OSDI scores and TOsm, while no significant difference was found in fluorescein TBUT, average NITBUT, first NITBUT and Schirmer test. The ocular surface may partially recover after the procedures, but IVI still has deleterious effects on the ocular surface.

摘要

目的

本研究旨在评估连续玻璃体内注射(IVI)对干眼指标的长期影响。

方法

根据 PROSPERO 方案(CRD42023455727),检索 PubMed、EMBASE 和 Cochrane 数据库。纳入评估与未治疗对侧眼相比,连续 IVI 对眼表影响的研究。将 IVI 后的干眼测量结果作为结局变量。结果表示为均数差(MD)及其相应的 95%置信区间(CI)。

结果

本 meta 分析共纳入 4 项研究,共 259 名参与者。与未治疗的对侧眼相比,IVI 治疗眼的眼表疾病指数(OSDI)评分(MD 10.26,95%CI 5.05 至 15.46,p <0.01)和泪膜渗透压(TOsm;MD 4.40,95%CI 0.87 至 7.92,p = 0.01)显著升高。两组间荧光素泪膜破裂时间(TBUT;p = 0.05)、平均非侵入性泪膜破裂时间(NITBUT;p = 0.94)、首次 NITBUT(p = 0.78)和 Schirmer 试验(p = 0.94)无显著差异。

结论

术前应用聚维酮碘的抗 VEGF 药物重复 IVI 与 OSDI 评分和 TOsm 升高相关,而荧光素 TBUT、平均 NITBUT、首次 NITBUT 和 Schirmer 试验无显著差异。尽管在治疗后眼表可能会部分恢复,但 IVI 仍对眼表有不良影响。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验